Качественная клиническая практика, 2020 No robust evidence proving clinical effectiveness of methylprednisolone in acute respiratory distress-syndrome in COVID-19, including combined use with tocilizumab, has been identified.
K. B. Mirzaev +2 more
doaj +1 more source
Наука телевидения, 2022 In this article, we analyze the image of healthcare and health professionals in the Russian television media agenda before and during the COVID-19 pandemic and determine the frequency and content of health-related news reports on federal and regional ...
NOR-AREVYAN OXANA A. / НОР-АРЕВЯН О.А. +2 more
doaj +1 more source
What could happen after the first wave of COVID-19 diffusion in Italy: learning from the 1918 influenza pandemic / Что могло произойти после первой волны эпидемии COVID-19 в Италии: опыт пандемии гриппа в 1918 году / Šta je moglo da se dogodi nakon prvog talasa širenja COVID-19 u Italiji - iskustva iz pandemije gripa 1918. godine [PDF]
Vojnotehnički Glasnik, 2020 Introduction/purpose: A comparison of the 1918 “Spanish” influenza to the 2020 COVID–19 pandemic could shed some light on the evolution of the latter.
Nicola Fabiano, Stojan N. Radenović
doaj +1 more source
Current and future use of angiotensin II receptor blockers in patients with COVID-19
Качественная клиническая практика, 2020 No scientific evidence for the negative influence of angiotensin II receptor blockers onto COVID-19 clinical course has been identified so far. Prescribing angiotensin II receptor blockers as COVID-19 pathogenetic therapy could only be considered within ...
A. V. Matveev +2 more
doaj +1 more source
Possibilities for the use of tofacitinib in patients with COVID-19
Качественная клиническая практика, 2020 No published trials measuring effectiveness of tofacitinib in COVID-19 have been identified. Some professional associations recommend discontinuing tofacitinib if SARS-CoV-2 infections is detected.
A. V. Matveev +2 more
doaj +1 more source
Current and future use of vitamin D3 in patients with COVID-19
Качественная клиническая практика, 2020 There is currently no evidence for vitamin D3 effectiveness for COVID-19 treatment and prevention.
I. N. Sychev +2 more
doaj +1 more source
Коронавирус – невидимый противник. Военная лексика в языковом образе пандемии в медийных текстах
Językoznawstwo, 2022 Во время пандемии коронавируса в национальных языках появились языковые инновации, но многие уже существующие слова также использовались для описания новой „коронавирусной” реальности.
Jolanta Jóźwiak
doaj +1 more source
Change of opinion on the use of hydroxychloroquine for COVID-19 treatment and prevention
Качественная клиническая практика, 2020 The use of hydroxychloroquine for COVID-19 treatment and prevention should be restricted in both out- and inpatient settings due to the lack of evidence for effectiveness and unfavorable safety profile.
K. B. Mirzaev, D. A. Sychev
doaj +1 more source
Adjusting the role of hydroxychloroquine with or without azithromycin in patients with COVID-19
Качественная клиническая практика, 2020 Taking recent publications into account, one should consider avoiding routine use of hydroxychloroquine, especially if combined with azithromycin, for COVID-19.
V. A. Otdelenov +4 more
doaj +1 more source
Биоикономическата активност в България в условия на коронавирус
Икономика и управление на селското стопанство, 2021 Стратегията на Европейския съюз предвижда развитие на биоикономиката като важен инструмент за постигане на интелигентен и зелен растеж. Тук се включват сектори, които произвеждат и използват биологични продукти.
Мария Коцева-Тикова +1 more
doaj